SCHEMBL26104758

SCHEMBL26104758

CCn1ccc2c(CO)cc(Cl)nc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.33
▸ HDAC4 P56524 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ PTGER4 P35408 1/20 0.31
▸ CYP19A1 P11511 4/20 0.30
▸ PDE4D Q08499 1/20 0.30
▸ CYP17A1 P05093 2/20 0.30
▸ CYP11B1 P15538 2/20 0.30
▸ MEN1 O00255 2/20 0.30
▸ TBXAS1 P24557 1/20 0.30
▸ ABCC4 O15439 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ PKM P14618 1/20 0.30
▸ PTGS1 P23219 1/20 0.30
▸ MAOB P27338 1/20 0.30
▸ HTR6 P50406 1/20 0.30
▸ KDM4E B2RXH2 2/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31347139 1.00 KMT2A (0.33) KMT2AHDAC4HDAC1HDAC6PTGER4
SCHEMBL26105348 0.84 TLR7 (0.39) HDAC4HDAC1HDAC6PDE4DLMNA
SCHEMBL31347050 0.84 TLR7 (0.39) HDAC4HDAC1HDAC6PDE4DLMNA
SCHEMBL26106366 0.82 JAK2 (0.31) HDAC4HDAC1HDAC6
SCHEMBL26105306 0.81 NOTUM (0.32) PDE4DKDM4EALDH1A1
SCHEMBL30612138 0.81 NOTUM (0.32) PDE4DKDM4EALDH1A1
SCHEMBL26109399 0.81 HRH4 (0.42) HDAC4HDAC1HDAC6CYP19A1LMNA
SCHEMBL30611967 0.81 LMNA (0.34) LMNAALDH1A1
SCHEMBL26106118 0.81 LMNA (0.34) LMNAALDH1A1
SCHEMBL30612079 0.80 GRIN2B (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499629-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2025-02-05 — — EP disclosed
WO-2023183919-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS ONCOPIA THERAPEUTICS, INC. D/B/A PROTEOVANT THERAPEUTICS, INC. (US) 2023-09-28 — — WO disclosed
Send feedback